CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Earnings (Deficit)
Beginning balance (in shares) at Dec. 31, 2020		33,442,332
Beginning balance at Dec. 31, 2020	$ 473,015	$ 329	$ 497,803	$ 0	$ (25,117)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)		7,000,000
Sale of common stock	100,870	$ 70	100,800
Offering costs	(188)		(188)
Stock-based compensation (in shares)		35,509
Stock‑based compensation	521		521
Other comprehensive income	263			263
Net income	15,740				15,740
Dividends declared	(14,248)				(14,248)
Ending balance (in shares) at Mar. 31, 2021		40,477,841
Ending balance at Mar. 31, 2021	575,973	$ 399	598,936	263	(23,625)
Beginning balance (in shares) at Dec. 31, 2020		33,442,332
Beginning balance at Dec. 31, 2020	473,015	$ 329	497,803	0	(25,117)
Increase (Decrease) in Stockholders' Equity
Other comprehensive income	117
Net income	33,355
Ending balance (in shares) at Jun. 30, 2021		47,001,121
Ending balance at Jun. 30, 2021	679,037	$ 464	700,994	117	(22,538)
Beginning balance (in shares) at Mar. 31, 2021		40,477,841
Beginning balance at Mar. 31, 2021	575,973	$ 399	598,936	263	(23,625)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)		6,500,000
Sale of common stock	101,790	$ 65	101,725
Offering costs	(164)		(164)
Stock-based compensation (in shares)		23,280
Stock‑based compensation	497		497
Other comprehensive income	(146)			(146)
Net income	17,615				17,615
Dividends declared	(16,528)				(16,528)
Ending balance (in shares) at Jun. 30, 2021		47,001,121
Ending balance at Jun. 30, 2021	679,037	$ 464	700,994	117	(22,538)
Increase (Decrease) in Stockholders' Equity
Offering costs	(52)		(52)
Stock-based compensation (in shares)		700
Stock‑based compensation	428		428
Other comprehensive income	(98)			(98)
Net income	9,951				9,951
Dividends declared	(16,523)				(16,523)
Ending balance (in shares) at Sep. 30, 2021		47,001,821
Ending balance at Sep. 30, 2021	672,743	$ 464	701,370	19	(29,110)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)		137,237
Sale of common stock	2,119	$ 1	2,118
Offering costs	(32)		(32)
Stock-based compensation (in shares)		5,000
Stock‑based compensation	494		494
Other comprehensive income	2,825			2,825
Net income	17,154				17,154
Dividends declared	$ (16,675)				(16,675)
Ending balance (in shares) at Dec. 31, 2021	47,144,058	47,144,058
Ending balance at Dec. 31, 2021	$ 678,628	$ 465	703,950	2,844	(28,631)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)		190,369
Sale of common stock	2,874	$ 2	2,872
Offering costs	(9)		(9)
Stock-based compensation (in shares)		78,009
Stock‑based compensation	766		766
Other comprehensive income	7,614			7,614
Net income	16,201				16,201
Dividends declared	(16,740)				(16,740)
Ending balance (in shares) at Mar. 31, 2022		47,412,436
Ending balance at Mar. 31, 2022	$ 689,334	$ 467	707,579	10,458	(29,170)
Beginning balance (in shares) at Dec. 31, 2021	47,144,058	47,144,058
Beginning balance at Dec. 31, 2021	$ 678,628	$ 465	703,950	2,844	(28,631)
Increase (Decrease) in Stockholders' Equity
Other comprehensive income	9,545
Net income	$ 26,231
Ending balance (in shares) at Jun. 30, 2022	54,438,363	54,438,363
Ending balance at Jun. 30, 2022	$ 786,000	$ 537	811,411	12,389	(38,337)
Beginning balance (in shares) at Mar. 31, 2022		47,412,436
Beginning balance at Mar. 31, 2022	689,334	$ 467	707,579	10,458	(29,170)
Increase (Decrease) in Stockholders' Equity
Sale of common stock (in shares)		7,000,000
Sale of common stock	103,393	$ 70	103,323
Offering costs	(190)		(190)
Stock-based compensation (in shares)		25,927
Stock‑based compensation	699		699
Other comprehensive income	1,931			1,931
Net income	10,031				10,031
Dividends declared	$ (19,198)				(19,198)
Ending balance (in shares) at Jun. 30, 2022	54,438,363	54,438,363
Ending balance at Jun. 30, 2022	$ 786,000	$ 537	$ 811,411	$ 12,389	$ (38,337)